Literature DB >> 2531122

Human glioma cell lines expressing the common acute lymphoblastic leukemia antigen (cALLa) have neutral endopeptidase activity.

L Monod1, A C Diserens, C V Jongeneel, S Carrel, P Ronco, P Verroust, N de Tribolet.   

Abstract

Several established human glioma cell lines have been previously shown to express the common acute lymphoblastic leukemia antigen (cALLa, CD 10), an important marker in the diagnosis of human acute lymphocytic leukemia (ALL). The amino acid sequence of cALLa is identical to that of neutral endopeptidase (NEP,E.C.3.4.24.11), and cALLa expressed on leukemia and melanoma cell lines is enzymatically active NEP. In the present study, we investigated whether cALLa expressed on glioma cell lines is active NEP. We detected cALLa on 10 out of 13 glioma cell lines using 2 different anti-cALLa MAbs (A12-G4 and FAH99). NEP antigen, as detected by immunostaining with an anti-NEP MAb (135A3), was expressed on the same 10 lines. cALLa-positive, but not cALLa-negative cell lines displayed an endopeptidase activity. This activity could be blocked by phosphoramidon, a specific inhibitor of NEP. Furthermore, mRNAs hybridizing to an NEP-specific probe were present in cALLa-positive glioma cells but not in cALLa-negative cells. Taken together, the results provide strong evidence that cALLa-positive glioma cell lines express endopeptidase activity on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531122     DOI: 10.1002/ijc.2910440533

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Towards the phenotyping of soft tissue tumours by cell surface molecules.

Authors:  G Mechtersheimer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  CD antigens as promising tools for the functional analysis of solid tumours.

Authors:  P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 3.  Factors influencing tumor cell traffic in the central nervous system.

Authors:  M L Rosenblum
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

Review 4.  Tumoral invasion in the central nervous system.

Authors:  Y A De Clerck; H Shimada; I Gonzalez-Gomez; C Raffel
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion.

Authors:  A P Amar; S J DeArmond; D R Spencer; P F Coopersmith; D M Ramos; M L Rosenblum
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Expression of cALLa/NEP on gliomas: a possible marker of malignancy.

Authors:  L Monod; M F Hamou; P Ronco; P Verroust; N de Tribolet
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

7.  Expression and release of interleukin-1 by human glioblastoma cells in vitro and in vivo.

Authors:  T Gauthier; M F Hamou; L Monod; P Gallay; S Carrel; N de Tribolet
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

8.  Human/mouse chimeric antibodies show low reactivity with human anti-murine antibodies (HAMA).

Authors:  M Hosono; K Endo; H Sakahara; Y Watanabe; T Saga; T Nakai; C Kawai; A Matsumori; T Yamada; T Watanabe
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.